EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial mGPDH Modulates Fibroblast Function in Diabetic Wound Healing via the SIRT1–c-Myc–TGF-β1 Axis

Ling Zhou, Yue Hong, Xing Li, Yuling Zhang, Linlin Zhang, Guiliang Peng, Hua Qu, Xiaoyu Liao, Mingyu Liao, Yongliang Yang, Liqing Cheng, Weiling Leng und 4 weitere

Diabetes · 01.03.2026 · 75 (3) · 427-440

DOI: 10.2337/db25-0539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 16.12.2025. Verfasst von Ling Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Southwest Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Wound Healing, Fibroblasts, Transforming Growth Factor beta1, Sirtuin 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chongqing Natural Science Foundation (Chongqing Science and Technology Development Foundation), Chongqing Natural Science Foundation General Project, Chongqing Natural Science Foundation (Chongqing Science and Technology Development Foundation) Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblasts play a pivotal role in wound healing, particularly during the proliferative and remodeling phase, where they migrate to the injury site, proliferate, and synthesize essential extracellular matrix (ECM) components such as collagen and fibronectin (FN). However, fibroblast functionality is compromised because of factors such as vascular dysfunction and oxidative stress in diabetic wounds, leading to chronic inflammation and delayed healing. This study investigates the role of mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), a key enzyme in energy metabolism, in regulating fibroblast function during diabetic wound healing. We demonstrate that mGPDH is overexpressed in diabetic wounds and in fibroblasts cultured under high-glucose conditions, contributing to impaired ECM repair. Importantly, the inhibition of mGPDH restores fibroblast functionality by enhancing ECM synthesis, increasing the levels of collagen IV and α-smooth muscle actin (α-SMA) proteins, and accelerating wound healing. Mechanistically, mGPDH deficiency activates the SIRT1–c-Myc–TGF-β1 signaling axis, resulting in reduced c-Myc protein stability, alleviation of its inhibitory effects on TGF-β1 signaling, and subsequent activation of ECM synthesis pathways. This study highlights the role of mGPDH in regulating fibroblast migration and ECM secretion, without affecting apoptosis or proliferation, thereby underscoring its selective regulatory role in wound healing. These findings establish mGPDH as a pivotal regulatory node in fibroblast function during diabetic wound healing, providing a foundation for the development of localized therapeutic strategies aimed at restoring fibroblast activity and improving wound healing outcomes in patients with diabetes. Article Highlights Mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) is elevated in diabetic wounds; its inhibition enhances extracellular matrix production and wound closure. mGPDH deficiency activates SIRT1, deacetylating c-Myc to boost TGF-β1 and extracellular matrix production synthesis genes. Targeted mGPDH inhibition can restore fibroblast function and accelerate wound healing in diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingFibroblastsTransforming Growth Factor beta1Sirtuin 1MitochondriaProto-Oncogene Proteins c-mycDiabetes Mellitus, ExperimentalAnimalsMiceSignal TransductionHumansExtracellular MatrixMaleCells, Cultured

Substanzen

Transforming Growth Factor beta1Sirtuin 1Proto-Oncogene Proteins c-mycSirt1 protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Department of Endocrinology, Jinling Hospital, Nanjing University, Nanjing, China.
  • Department of Endocrinology, Translational Research Key Laboratory for Diabetes, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • State Key Laboratory of Robotics, Shenyang Institute of Automation, Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, China.

ORCID-Profile: Min Long

Förderung

  • Chongqing Natural Science Foundation (Chongqing Science and Technology Development Foundation)
  • Chongqing Natural Science Foundation General Project
  • Chongqing Natural Science Foundation (Chongqing Science and Technology Development Foundation) Key Project

Zitieren

APA

Zhou, L., Hong, Y., Li, X., Zhang, Y., Zhang, L., Peng, G., Qu, H., Liao, X., Liao, M., Yang, Y., Cheng, L., Leng, W., Zheng, Y., Zhang, Y., Zheng, H., & Long, M. (2026). Mitochondrial mGPDH Modulates Fibroblast Function in Diabetic Wound Healing via the SIRT1–c-Myc–TGF-β1 Axis. Diabetes, 75(3), 427-440. https://doi.org/10.2337/db25-0539

Vancouver

Zhou L, Hong Y, Li X, Zhang Y, Zhang L, Peng G, et al. Mitochondrial mGPDH Modulates Fibroblast Function in Diabetic Wound Healing via the SIRT1–c-Myc–TGF-β1 Axis. Diabetes. 2026;75(3):427-440. doi:10.2337/db25-0539

BibTeX
@article{Zhou2026,
  author = {Zhou, Ling and Hong, Yue and Li, Xing and Zhang, Yuling and Zhang, Linlin and Peng, Guiliang and Qu, Hua and Liao, Xiaoyu and Liao, Mingyu and Yang, Yongliang and Cheng, Liqing and Leng, Weiling and Zheng, Yanling and Zhang, Yanlin and Zheng, Hongting and Long, Min},
  title = {Mitochondrial mGPDH Modulates Fibroblast Function in Diabetic Wound Healing via the SIRT1–c-Myc–TGF-β1 Axis},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {3},
  pages = {427--440},
  doi = {10.2337/db25-0539}
}
Kostenlos starten →